QR-6401 is an orally active and selective macrocyclic CDK2 inhibitor with IC 50 values of 0.37, 10, 22, 34 and 45 nM for CDK2/E1 , CDK9/T1 , CDK1/A2 , CDK6/D3 and CDK4/D1 , respectively. QR-6401 has potent antitumor activity in an OVCAR3 ovarian cancer xenograft model. QR-6401 has the potential to be used in the study of cancer .
Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > CDK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.